Management of late distant metastases after trimodality therapy for esophageal cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 14602333.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Trimodality therapy has been shown in preliminary studies to increase survival in esophageal cancer. Distant recurrence remains the main pattern of failure. A case of aggressive treatment of two metachronous solitary visceral metastases is presented.
Medical subject headings
- Adenocarcinoma
- Brain Neoplasms
- Esophageal Neoplasms